Bioscan is a leading developer of advanced instrumentation for the detection, synthesis, and imaging of Radio labeled Compounds used in four areas:
- Life Science Research
- Molecular Imaging
- Pharmaceutical Development
- Nuclear Medicine
Founded in 1980, Bioscan has supplied customers with unique research productivity tools for more than 25 years.
Thousands of customers worldwide--in universities, research hospitals, government laboratories, and pharmaceutical companies--use Bioscan products for basic biomedical research and for the production of radiopharmaceuticals.
With the introduction of its NanoSPECT/CT in vivo imaging system in 2006 and the NanoPET/CT in 2010, Bioscan set a new standard in the field of molecular imaging of animal models for biological & disease research.
Bioscan facilitates early disease diagnosis--and accelerates drug discovery--by providing innovative technologies for bio-tracer chemistry and preclinical imaging. Our goal is to provide researchers with reliable, flexible, and easy-to-use instrumentation that offers state-of-the-art performance capabilities.
